Bio-Techne Corp (NAS:TECH)
$ 74.505 0.83 (1.13%) Market Cap: 11.74 Bil Enterprise Value: 11.96 Bil PE Ratio: 59.12 PB Ratio: 5.82 GF Score: 95/100

Bio-Techne Corp at Citi Healthcare Conference (Virtual) Transcript

Feb 24, 2022 / 03:15PM GMT
Release Date Price: $103.23 (+5.23%)
Patrick Bernard Donnelly
Citigroup Inc., Research Division - Senior Analyst

Well, great. Thank you all for joining us at the Citi Conference here. I'm Patrick Donnelly, the Tools and Diagnostics Analyst at Citi.

Happy to have Jim Hippel, CFO of Techne; and Dave Clair from the IR team. And we can dive right in, Jim.

Questions & Answers

Patrick Bernard Donnelly
Citigroup Inc., Research Division - Senior Analyst

I guess, going back a few weeks, you guys reported a pretty clean beat in your fiscal 2Q. Protein Sciences continues to be a source of strength. Maybe just at a high level, we can start with the quarter, maybe talk through kind of the moving pieces and then we can kind of dive into some more specific questions.

James T. Hippel
Bio-Techne Corporation - Executive VP of Finance & CFO

Yes. I mean it was a great quarter. It was a very strong broad-based growth quarter as it has been now for many quarters in a row for our business. As you mentioned, the Protein Science, in particular, is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot